Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
Weber MS, Prod'homme T, Youssef S, Dunn SE, Steinman L, Zamvil SS
J Neuroinflammation. 2014; 11(1):29. Epub 2014 Feb 06. PMID: 24498870.Abstract